MoneyWorks4Me

Biocon board to consider the unaudited financial result

04 Oct 2013 Evaluate

Biocon has informed that a meeting of the Board of Directors of the Company will be held on October 24, 2013, to approve and take on record the unaudited financial results of the Company for the quarter and half year ended September 30, 2013 (Q2).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..